Clinical Trial

Study on c-Met Targeted PET/CT Imaging in NSCLC

Recruiting
View on ClinicalTrials.gov →
Summary
The investigators developed a 18F labeled small molecule, 18F-TSPF, based on c-Met TKI, as a targeted molecular imaging agent for noninvasive and repeatable detecting c-Met activation status.
Trial Details
NCT Number NCT06911697
Lead Sponsor Xilin Sun
Collaborators: Henan Provincial People's Hospital
Conditions PET/CT Imaging, NSCLC
Enrollment 88 participants
Start Date 2023-10-26
Primary Completion 2025-03-28 (estimated)
Study Completion 2025-06-28 (estimated)
Updated on ClinicalTrials.gov 2025-04-04